PMID- 20726378
OWN - NLM
STAT- MEDLINE
DCOM- 20100902
LR  - 20100823
IS  - 0888-5109 (Print)
IS  - 0888-5109 (Linking)
VI  - 25 Suppl B
DP  - 2010 Jun
TI  - Prediabetes in a nursing facility patient with renal insufficiency.
PG  - 11-8
AB  - OBJECTIVES: Prediabetes encompasses a variety of abnormalities, including 
      impaired fasting glucose, impaired glucose tolerance, and metabolic syndrome. 
      Prediabetes also increases the risk of developing type 2 diabetes mellitus (T2DM) 
      by 3- to 10-fold, but the complications associated with hyperglycemia begin early 
      in the patient's progression from normal glucose levels to diabetes. Early 
      identification and treatment of prediabetes has the potential to reduce or delay 
      progression to overt diabetes, to preempt related cardiovascular and 
      microvascular disease, and to significantly improve morbidity and mortality. This 
      clinical review provides a vehicle to examine management of prediabetes in 
      patients 65 years of age and older, including diagnostic criteria and 
      recommendations for management. DATA SOURCES: Live symposium presentation based 
      on clinical practice and research, medical literature, and studies published 
      between May 1999 and March 2010 on managing diabetes in older adults, government 
      statistics, and medical society guidelines. CONCLUSIONS: Effective prediabetes 
      management is important to reducing the risk of progression to T2DM. Recommended 
      first-line therapy is lifestyle modification that may include exercise, 
      nutritional therapy, and weight loss. Pharmacological therapies, when indicated, 
      can aid in improving glucose, blood pressure, and lipid parameters in this 
      patient subgroup.
FAU - Shane-McWhorter, Laura
AU  - Shane-McWhorter L
AD  - Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake 
      City, Utah 84112, USA. lmcwhorter@pharm.utah.edu
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Consult Pharm
JT  - The Consultant pharmacist : the journal of the American Society of Consultant 
      Pharmacists
JID - 9013983
RN  - 0 (Blood Glucose)
RN  - 0 (Lipids)
SB  - IM
MH  - Aged
MH  - Blood Glucose/drug effects
MH  - Blood Pressure/drug effects
MH  - Diabetes Mellitus, Type 2/etiology/*prevention & control
MH  - Disease Progression
MH  - Humans
MH  - Life Style
MH  - Lipids/blood
MH  - Male
MH  - Mass Screening/methods
MH  - Nursing Homes
MH  - Prediabetic State/complications/diagnosis/*therapy
MH  - Renal Insufficiency/*complications
MH  - Risk Factors
EDAT- 2010/08/24 06:00
MHDA- 2010/09/03 06:00
CRDT- 2010/08/24 06:00
PHST- 2010/08/24 06:00 [entrez]
PHST- 2010/08/24 06:00 [pubmed]
PHST- 2010/09/03 06:00 [medline]
PST - ppublish
SO  - Consult Pharm. 2010 Jun;25 Suppl B:11-8.